Silk Road Medical Announces First Patient Enrolled in ROADSTER 3 Post Approval Study…
SUNNYVALE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced…